Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 119

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 119
---
                          |  6.95 | % |     | $                                                                      | 14,000,000 |

| (1) | This                                                                                             
 column excludes the 131,909 Commitment Shares that we issued to Yorkville upon the execution     
 of the SEPA on October 24, 2025 and excludes the up to 4,000,000 Conversion Shares that may      
 be issued to Yorkville at a Fixed Price upon conversion of the Convertible Notes issued to       
 Yorkville under the SEPA. Although the SEPA provides that we may sell up to $20,000,000 of       
 our common stock to Yorkville, we are only registering 10,000,000 shares under the initial       
 Registration Statement that includes this prospectus. Such shares of common stock include        
 (i) up to 4,000,000 Conversion Shares that may be issued to Yorkville upon conversion by         
 Yorkville of Convertible Notes issued to Yorkville under the SEPA, (ii) 5,868,091 Advance        
 Shares that may be issued to Yorkville pursuant to one or more Advances under the SEPA and       
 (iii) 131,909 Commitment Shares (which may or may not cover all of the shares we ultimately      
 sell to Yorkville under the SEPA). We will not issue more than the Exchange Cap (an aggregate    
 of 6,855,459 shares of our common stock) unless otherwise approved by our stockholders to        
 do so (which stockholder approval we are seeking to obtain from our stockholders at the upcoming 
 2025 Annual Meeting of Stockholders to be convened on December 19, 2025). The number of shares   
 to be issued as set forth in this column is limited to the 5,868,091 Advance Shares being        
 registered for resale hereunder. If we elect to issue and sell to Yorkville more than the        
 10,000,000 shares of common stock, we must first (i) obtain stockholder approval to issue        
 shares of common stock in excess of the Exchange Cap under the SEPA and (ii) file with the       
 SEC one or more additional registration statements to register under the Securities Act for      
 the offer and resale by Yorkville of any such additional shares of our common stock we wish      
 to sell from time to time under the SEPA, which the SEC must declare effective, in each case     
 before we may elect to sell any additional shares of our common stock to Yorkville under         
 the SEPA.                                                                                        |